Technological Marvels Ready Natural Products for Drug Discovery

FNL HIV Investigator Brandon Keele Shapes Peer Research with Multiple Seminal and Highly Cited Papers

FNL Biopharma Development Program Set to Manufacture CAR-T Cell Therapy

Team to support CAR-T cell clinical trial in pediatric acute myeloid leukemia

Research Team Finds TTK Inhibitor Kills Lung Cancer Cells and Tumors in Mice

The work was published by FNL Director Ethan Dmitrovsky, M.D. and his team.

FNL is a Key Partner in Foundation for the NIH Collaboration

Partnership aims to address critical need in liquid biopsy research.

Frederick National Laboratory Part of SC19 “Best Paper” Team

A multidisciplinary team including members of the Frederick National Laboratory has been recognized with the “Best Paper” award at SC19.

National Lab Team Harnesses Metabolism for Therapy in Pancreatic Cancer

FNL’s Hyun Jung Takes First Place at Medical Imaging Grand Challenge

The challenge featured nearly 1,000 competitors from around the world.

Ebola Study a Source of Hope and Humanity During Violence, Danger, and Disease

FNL supports Ebola clinical studies in DRC.

Guided Missiles Against Tumors

Using Precision Medicine, Scientists Take Aim at Many Types of Cancer

RAS Initiative Has Replaced Mystery with Momentum

The NCI RAS Initiative has quickly helped to reverse the field’s perspective on a problem long considered unsolvable.

Cell Division Rates and Cancer Risk Decelerate in Very Old People, but Not in Very Old Mice

Baktiar Karim in the Molecular Histopathology Laboratory.

Survivor Brings Drive and Rare Personal Perspective to Ebola Virus Disease Reasearch

The Single-Dose Solution

Reducing the HPV vaccine from three doses to one could dramatically improve global immunization rates.